C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 7/16 (2006.01) A61K 38/08 (2006.01) A61K 38/11 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2163114
A peptide having formula a) wherein Mpa is 3-mercaptopropionic acid residue (-S CH2 CH2-CO); X is D-trytophan (D Trp) or .beta.-(2-Naphtyl)-D-alanine (D Nal); Ile is isoleucine; Y is alloisolencine (alloIle) or (S)-2-Amino-3-ethyl-pentanoic acid (Ala(.beta.-Et2)); Asn is asparqgine; .alpha.-Abu is .alpha.-aminobutyric acid residue (II) and N.alpha.MeOm is N.alpha.-methyl-ornithine, is disclosed. The peptides may be used as an active ingredient in a medicament, especially in a pharmaceutical composition for therapeutic treatment of excessive uterus muscle contractions.
L'invention concerne un peptide ayant la formule (I) dans laquelle Mpa représente un reste d'acide 3-mercaptopropionique (-S-CH2-CH2-CO-), X représente D-tryptophan (D-Trp) ou beta -(2-Naphtyl)-D-alanine (D-Nal), Ile représente isoleucine, Y représente alloisoleucine (alloIle) ou l'acide (S)-2-Amino-3-éthyl-pentanoïque (Ala( beta -Et2)), Asn représente asparagine, alpha -Abu représente un reste d'acide alpha -aminobutyrique de la formule (II) et N alpha MeOrn représente N alpha -méthyl-ornithine. Les peptides peuvent être utilisés comme ingrédients actifs dans un médicament, notamment dans une composition pharmaceutique destinée au traitement thérapeutique des contractions musculaires excessives de l'utérus.
Aurell Carl-Johan
Melin Per
Nilsson Anders
Trojnar Jerzy
Ferring B.v.
Fetherstonhaugh & Co.
LandOfFree
Peptides exhibiting oxytocin antagonistic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides exhibiting oxytocin antagonistic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides exhibiting oxytocin antagonistic activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1694074